• Explore /
  • Poster
  • / Impact of age, prior therapies, and subsequent transplant on long-term outcomes of adults with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with brexucabtagene autoleucel (brexu-cel) in ZUMA-3.

Impact of age, prior therapies, and subsequent transplant on long-term outcomes of adults with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with brexucabtagene autoleucel (brexu-cel) in ZUMA-3.

Abstract Video & Slides Poster

Authors

null

Bijal D. Shah

Moffitt Cancer Center, Tampa, FL

Bijal D. Shah , Ryan Daniel Cassaday , Jae H. Park , Roch Houot , Olalekan O. Oluwole , Aaron Logan , Nicolas Boissel , Thibaut Leguay , Michael Russell Bishop , Max S. Topp , Kristen M. O'Dwyer , Maria R. Baer , Gary J. Schiller , Mehrdad Abedi , Monique C. Minnema , Patrick J. Stiff , Lang Zhou , Tsveta Hadjivassileva , Rita Damico Khalid , Armin Ghobadi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Acute Leukemia

Clinical Trial Registration Number

NCT02614066

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 7023)

DOI

10.1200/JCO.2023.41.16_suppl.7023

Abstract #

7023

Poster Bd #

153

Abstract Disclosures

Similar Posters

First Author: Olalekan O. Oluwole

First Author: Bijal D. Shah

First Author: Dok Hyun Yoon

First Author: Karnav Modi